These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29154744)

  • 1. Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.
    Duffy MR; Alonso-Padilla J; John L; Chandra N; Khan S; Ballmann MZ; Lipiec A; Heemskerk E; Custers J; Arnberg N; Havenga M; Baker AH; Lemckert A
    J Gen Virol; 2018 Jan; 99(1):135-147. PubMed ID: 29154744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
    Ballmann MZ; Raus S; Engelhart R; Kaján GL; Beqqali A; Hadoke PWF; van der Zalm C; Papp T; John L; Khan S; Boedhoe S; Danskog K; Frängsmyr L; Custers J; Bakker WAM; van der Schaar HM; Arnberg N; Lemckert AAC; Havenga M; Baker AH
    J Virol; 2021 Oct; 95(22):e0038721. PubMed ID: 34469243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
    Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
    Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Evaluation of Human Adenovirus Type 49 as a Vector for Therapeutic Applications.
    Bates EA; Counsell JR; Alizert S; Baker AT; Suff N; Boyle A; Bradshaw AC; Waddington SN; Nicklin SA; Baker AH; Parker AL
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
    Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
    Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.
    Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R
    PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice.
    Dicks MD; Spencer AJ; Coughlan L; Bauza K; Gilbert SC; Hill AV; Cottingham MG
    Sci Rep; 2015 Nov; 5():16756. PubMed ID: 26576856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus-based vaccines: comparison of vectors from three species of adenoviridae.
    Chen H; Xiang ZQ; Li Y; Kurupati RK; Jia B; Bian A; Zhou DM; Hutnick N; Yuan S; Gray C; Serwanga J; Auma B; Kaleebu P; Zhou X; Betts MR; Ertl HC
    J Virol; 2010 Oct; 84(20):10522-32. PubMed ID: 20686035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector".
    Yan Y; Jing S; Feng L; Zhang J; Zeng Z; Li M; Zhao S; Ou J; Lan W; Guan W; Wu X; Wu J; Seto D; Zhang Q
    Virol Sin; 2021 Jun; 36(3):354-364. PubMed ID: 32458297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
    Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
    J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
    Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R
    Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.
    Dicks MD; Guzman E; Spencer AJ; Gilbert SC; Charleston B; Hill AV; Cottingham MG
    Vaccine; 2015 Feb; 33(9):1121-8. PubMed ID: 25629523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.
    Lemckert AAC; Grimbergen J; Smits S; Hartkoorn E; Holterman L; Berkhout B; Barouch DH; Vogels R; Quax P; Goudsmit J; Havenga MJE
    J Gen Virol; 2006 Oct; 87(Pt 10):2891-2899. PubMed ID: 16963747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies.
    Wortmann A; Vöhringer S; Engler T; Corjon S; Schirmbeck R; Reimann J; Kochanek S; Kreppel F
    Mol Ther; 2008 Jan; 16(1):154-62. PubMed ID: 17848961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
    Sumida SM; Truitt DM; Lemckert AA; Vogels R; Custers JH; Addo MM; Lockman S; Peter T; Peyerl FW; Kishko MG; Jackson SS; Gorgone DA; Lifton MA; Essex M; Walker BD; Goudsmit J; Havenga MJ; Barouch DH
    J Immunol; 2005 Jun; 174(11):7179-85. PubMed ID: 15905562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fiber Knob Protein of Human Adenovirus Type 49 Mediates Highly Efficient and Promiscuous Infection of Cancer Cell Lines Using a Novel Cell Entry Mechanism.
    Baker AT; Davies JA; Bates EA; Moses E; Mundy RM; Marlow G; Cole DK; Bliss CM; Rizkallah PJ; Parker AL
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33268514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Group B Streptococcus Induces a Robust IFN-γ Response by CD4(+) T Cells in an In Vitro and In Vivo Model.
    Clarke D; Letendre C; Lecours MP; Lemire P; Galbas T; Thibodeau J; Segura M
    J Immunol Res; 2016; 2016():5290604. PubMed ID: 26989699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.
    Sparer TE; Wynn SG; Clark DJ; Kaplan JM; Cardoza LM; Wadsworth SC; Smith AE; Gooding LR
    J Virol; 1997 Mar; 71(3):2277-84. PubMed ID: 9032363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant adenovirus vectors expressing interleukin-5 and -6 specifically enhance mucosal immunoglobulin A responses in the lung.
    Braciak TA; Gallichan WS; Graham FL; Richards CD; Ramsay AJ; Rosenthal KL; Gauldie J
    Immunology; 2000 Nov; 101(3):388-96. PubMed ID: 11106943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.